跳至主要内容
临床试验/ISRCTN12539707
ISRCTN12539707已完成未知

The role of the P-53 gene and the P-53 Protein in the oncogenesis of non-Hodgkin malignant lymphomas

Titu Maiorescu University0 个研究点目标入组 20 人开始时间: 2022年11月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

2018 Other publications in https://doi.org/10.1016/j.biopha.2018.06.072 Review (added 03/05/2023) Results article in https://www.ajsccr.org/article-details.php?tit=AJSCCR-v6-1840 (added 03/05/2023)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Patients diagnosed with CLL-B who were hospitalized in the Hematology departments of the Targu Mures Oncology Institute and Cluj-Napoca between November 2016 and September 2019
  • 2. CLL with> 5000 lymphocytes in absolute value, present at the cytological examination of the blood smear, from the peripheral blood or LLC with less than 10% prolymphocytes based on the peripheral blood smears May-Grunwald Giemsa, stained

排除标准

  • Does not meet inclusion criteria

研究者

发起方
Titu Maiorescu University

相似试验